Serum S-100B protein in severe head injury

Neurosurgery

Volumn 45, Issue 3, 1999, Pages 477-483

  Raabe, Andreas ^a,c   Grolms, Cornelia ^b   Sorge, Oliver ^a   Zimmermann, Michael ^a   Seifert, Volker ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b KLINIKUM CHEMNITZ   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Computed tomography; Head injury; Outcome; S 100 protein

Indexed keywords

PROTEIN S 100;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN INJURY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MARKER; FEMALE; HEAD INJURY; HUMAN; INJURY SCALE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN; CRANIOCEREBRAL TRAUMA; FEMALE; FOLLOW-UP STUDIES; GLASGOW COMA SCALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032878783     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199909000-00012     Document Type: Article

References (45)

1. Abraha HD, Butterworth RJ, Bath PM, Wassif WS, Garthwaite J, Sherwood RA: Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann Clin Biochem 34:546-550, 1997.
2. Alling C, Karlsson B, Vallfors B: Increase in myelin basic protein in CSF after brain surgery. J Neurol 223:225-230, 1980.
3. Astudillo R, van der Linden J, Radegran K, Hansson LO, Aberg B: Elevated serum levels of S-100 after deep hypothermic arrest correlate with duration of circulatory arrest. Eur J Cardiothorac Surg 10:1107-1113, 1996.
4. Aurell A, Rosengren LE, Karlsson B, Olsson JE, Zbornikova V, Haglid KG: Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke 22:1254-1258, 1991.
5. Bakay RA, Ward AAJ: Enzymatic changes in serum and cerebrospinal fluid in neurological injury. J Neurosurg 58:27-37, 1983.
6. Buttner T, Weyers S, Postert T, Sprengelmeyer R, Kuhn W: S-100 protein: Serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke 28:1961-1965, 1997.
7. Clatterbuck RE, Sipos EP: The efficient calculation of neurosurgically relevant volumes from computed tomographic scans using Cavalieri's Direct Estimator. Neurosurgery 40:339-342, 1997.
8. Cooper PR, Chalif DJ, Ramsey JF, Moore RJ: Radioimmunoassay of the brain type isoenzyme of creatine phosphokinase (CK-BB): A new diagnostic tool in the evaluation of patients with head injury. Neurosurgery 12:536-541, 1983.
9. Fagnart OC, Sindic CJ, Laterre C: Particle counting immunoassay of S100 protein in serum: Possible relevance in tumors and ischemic disorders of the central nervous system. Clin Chem 34:1387-1391, 1988.
10. Guo HB, Stoffel-Wagner B, Bierwirth T, Mezger J, Klingmuller D: Clinical significance of serum S100 in metastatic malignant melanoma. Eur J Cancer 31A:1898-1902, 1995.
11. Hans P, Born JD, Chapelle JP, Milbouw G: Creatine kinase isoenzymes in severe head injury. J Neurosurg 58:689-692, 1983.
12. Hardemark HG, Almqvist O, Johansson T, Pahlman S, Persson L: S-100 protein in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: Relation to functional outcome, late CT and SPECT changes, and signs of higher cortical dysfunction. Acta Neurochir (Wien) 99:135-144, 1989.
13. Hardemark HG, Ericsson N, Kotwica Z, Rundstrom G, Mendel-Hartvig I, Olsson Y, Pahlman S, Persson L: S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J Neurosurg 71:727-731, 1989.
14. Ingebrigtsen T, Romner B: Serial S-100 protein serum measurements related to early magnetic resonance imaging after minor head injury: Case report. J Neurosurg 85:945-948, 1996.
15. Ingebrigtsen T, Romner B, Kongstad P, Langbakk B: Increased serum concentrations of protein S-100 after minor head injury: A biochemical serum marker with prognostic value? J Neurol Neurosurg Psychiatry 59:103-104, 1995 (letter).
16. Jennett B, Bond M: Assessment of outcome after severe brain damage. Lancet 1:480-484, 1975.
17. Johnsson P: Markers of cerebral ischemia after cardiac surgery. J Cardiothorac Vasc Anesth 10:120-126, 1996.
18. Johnsson P, Lundqvist C, Lindgren A, Ferencz I, Ailing C, Stahl E: Cerebral complications after cardiac surgery assessed by S-100 and NSE levels in blood. J Cardiothorac Vasc Anesth 9:694-699, 1995.
19. Kim JS, Yoon SS, Kim YH, Ryu JS: Serial measurement of interleukin-6, transforming growth factor-β, and S-100 protein in patients with acute stroke. Stroke 27:1553-1557, 1996.
20. Langbakk B, Romner B: Age and sex-related changes of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorders. Clin Chem 43:541-543, 1997.
21. Marshall LF, Marshall SB, Klauber MR, van Berkum-Clark M, Eisenberg HM, Jane JA, Luerssen TG, Marmarou A, Foulkes MA: A new classification of head injury based on computerized tomography. J Neurosurg 75[Suppl]:S14-S20, 1991.
22. Michetti F, Massaro A, Murazio M: The nervous system-specific S-100 antigen in cerebrospinal fluid of multiple sclerosis patients. Neurosci Lett 11:171-175, 1979.
23. Michetti F, Massaro A, Russo G, Rigon G: The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system. J Neurol Sci 44:259-263, 1980.
24. Miliotes G, Lyman GH, Cruse CW, Puleo C, Albertini PA, Rapaport D, Glass F, Fenske N, Soriano T, Cuny C, Van Voorhis N, Reintgen D: Evaluation of new putative tumor markers for melanoma. Ann Surg Oncol 3:558-563, 1996.
25. Missler U, Wiesmann M, Friedrich C, Kaps M: S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 28:1956-1960, 1997.
26. Mokuno K, Kato K, Kawai K, Matsuoka Y, Yanagi T, Sobue I: Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases. J Neurol Sci 60:443-451, 1983.
27. Nordby HK, Urdal P: Creatine kinase BB in blood as index of prognosis and effect of treatment after severe head injury. Acta Neurochir (Wien) 76:131-136, 1985.
28. Persson L, Hardemark H, Edner G, Ronne E, Mendel Hartvig I, Pahlman S: S-100 protein in cerebrospinal fluid of patients with subarachnoid haemorrhage: A potential marker of brain damage. Acta Neurochir (Wien) 93:116-122, 1988.
29. Persson L, Hardemark HG, Gustafsson J, Rundstrom G, Mendel Hartvig I, Esscher T, Pahlman S: S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system. Stroke 18:911-918, 1987.
30. Raabe A, Grolms C, Keller M, Dohnert J, Sorge O, Seifert V: Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir (Wien) 140:787-791, 1998.
31. Raabe A, Menon DK, Gupta S, Czosnyka M, Pickard JD: Jugular venous and arterial concentrations of serum S-100B protein in patients with severe head injury: A pilot study. J Neurol Neurosurg Psychiatry 65:930-932, 1998.
32. Rabow L, Hedman G: CKBB-isoenzymes as a sign of cerebral injury. Acta Neurochir Suppl (Wien) 28:108-112, 1979.
33. Rao CJ, Shukla PK, Mohanty S, Reddy YJ: Predictive value of serum lactate dehydrogenase in head injury. J Neurol Neurosurg Psychiatry 41:948-953, 1978.
34. Taggart DP, Mazel JW, Bhattacharya K, Meston N, Standing SJ, Kay JD, Pillai R, Johnsson P, Westaby S: Comparison of serum S-100β levels during CABG and intracardiac operations. Ann Thorac Surg 63:492-196, 1997.
35. Takayasu M, Shibuya M, Kanamori M, Suzuki Y, Ogura K, Kageyama N, Umekawa H, Hidaka H: S-100 protein and calmodulin levels in cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 63:417-420, 1985.
36. Teasdale G, Jennett B: Assessment of coma and impaired consciousness: A practical scale. Lancet 2:81-84, 1974.
37. Thomas DG, Rowan TD: Lactic dehydrogenase isoenzymes following head injury. Injury 7:258-262, 1976.
38. Thomas DG, Hoyle NR, Seeldrayers P: Myelin basic protein immunoreactivity in serum of neurosurgical patients. J Neurol Neurosurg Psychiatry 47:173-175, 1984.
39. Thomas DG, Palfreyman JW, Ratcliffe JG: Serum-myelin-basic-protein assay in diagnosis and prognosis of patients with head injury. Lancet 1:113-115, 1978.
40. Usui A, Kato K, Abe T, Murase M, Tanaka M, Takeuchi E: S-100ao protein in blood and urine during open-heart surgery. Clin Chem 35:1942-1944, 1989.
41. Vollmer DG: Prognosis and outcome of severe head injury, in Cooper PR (ed): Head Injury. Baltimore, Williams & Wilkins, 1993, pp 553-581.
42. von Schoultz E, Hansson LO, Djureen E, Hansson J, Karnell R, Nilsson B, Stigbrand T, Ringborg U: Prognostic value of serum analyses of S-100β protein in malignant melanoma. Melanoma Res 6:133-137, 1996.
43. Westaby S, Johnsson P, Parry AJ, Blomqvist S, Solem JO, Ailing C, Pillai R, Taggart DP, Grebenik C, Stahl E: Serum S100 protein: A potential marker for cerebral events during cardiopulmonary bypass. Ann Thorac Surg 61:88-92, 1996.
44. Wiesmann M, Missler U, Hagenstrom H, Gottmann D: S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 139:1155-1160, 1997.
45. Woertgen C, Rothoerl RD, Holzschuh M, Metz C, Brawanski A: Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir (Wien) 139:1161-1165, 1997.